| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Integrated Genomic Approach to the Assessment and Treatment of Acute Myeloid Leukemia
|
Godley, Lucy A.
|
|
2011
|
38 |
2 |
p. 215-224
10 p.
|
artikel
|
| 2 |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Pancytopenia and Chylothorax
|
Thomas, Lisa C.
|
|
2011
|
38 |
2 |
p. 165-170
6 p.
|
artikel
|
| 3 |
Contents
|
|
|
2011
|
38 |
2 |
p. A1-A2
nvt p.
|
artikel
|
| 4 |
CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine
|
de Souza, Jonas A.
|
|
2011
|
38 |
2 |
p. 263-273
11 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2011
|
38 |
2 |
p. A9-
1 p.
|
artikel
|
| 6 |
Future and Previous Issues
|
|
|
2011
|
38 |
2 |
p. A11-
1 p.
|
artikel
|
| 7 |
Gene Mutations, Epigenetic Dysregulation, and Personalized Therapy in Myeloid Neoplasia: Are We There Yet?
|
Odenike, Olatoyosi
|
|
2011
|
38 |
2 |
p. 196-214
19 p.
|
artikel
|
| 8 |
Individualized Decision-Making for Older Men With Prostate Cancer: Balancing Cancer Control With Treatment Consequences Across the Clinical Spectrum
|
Sajid, Saleha
|
|
2011
|
38 |
2 |
p. 309-325
17 p.
|
artikel
|
| 9 |
Masthead
|
|
|
2011
|
38 |
2 |
p. IFC-
1 p.
|
artikel
|
| 10 |
Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges
|
Nicholas, M. Kelly
|
|
2011
|
38 |
2 |
p. 243-253
11 p.
|
artikel
|
| 11 |
Molecular Profiling of Cancer—The Future of Personalized Cancer Medicine: A Primer on Cancer Biology and the Tools Necessary to Bring Molecular Testing to the Clinic
|
Stricker, Thomas
|
|
2011
|
38 |
2 |
p. 173-185
13 p.
|
artikel
|
| 12 |
Molecular Profiling of Melanoma and the Evolution of Patient-Specific Therapy
|
Gajewski, Thomas F.
|
|
2011
|
38 |
2 |
p. 236-242
7 p.
|
artikel
|
| 13 |
Personalized Colon Cancer Care in 2010
|
Catenacci, Daniel V.T.
|
|
2011
|
38 |
2 |
p. 284-308
25 p.
|
artikel
|
| 14 |
Personalized Treatment of Lung Cancer
|
Salgia, Ravi
|
|
2011
|
38 |
2 |
p. 274-283
10 p.
|
artikel
|
| 15 |
Personalized Treatment of Lymphoma: Promise and Reality
|
Ramsdale, Erika
|
|
2011
|
38 |
2 |
p. 225-235
11 p.
|
artikel
|
| 16 |
“Targeting” Triple-Negative Breast Cancer: The Lessons Learned From BRCA1-Associated Breast Cancers
|
Nanda, Rita
|
|
2011
|
38 |
2 |
p. 254-262
9 p.
|
artikel
|
| 17 |
The Use of Genomic Information to Optimize Cancer Chemotherapy
|
Innocenti, Federico
|
|
2011
|
38 |
2 |
p. 186-195
10 p.
|
artikel
|
| 18 |
Tumor Heterogeneity as the Foundation of Personalized Cancer Treatment
|
Schilsky, Richard L.
|
|
2011
|
38 |
2 |
p. 171-172
2 p.
|
artikel
|
| 19 |
What's on the Agenda for 2011?
|
Crisafulli, Tony
|
|
2011
|
38 |
2 |
p. 163-164
2 p.
|
artikel
|
Tijdschrift beschrijving